The store will not work correctly when cookies are disabled.
5-((1,3-Dioxo-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-methyl)-N-hydroxy-[1,1'-biphenyl]-2-carboxamide
ID: ALA4776825
PubChem CID: 162643011
Max Phase: Preclinical
Molecular Formula: C21H15N3O4
Molecular Weight: 373.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NO)c1ccc(CN2C(=O)c3ccncc3C2=O)cc1-c1ccccc1
Standard InChI: InChI=1S/C21H15N3O4/c25-19(23-28)15-7-6-13(10-17(15)14-4-2-1-3-5-14)12-24-20(26)16-8-9-22-11-18(16)21(24)27/h1-11,28H,12H2,(H,23,25)
Standard InChI Key: IQPWCCOIBLQJFA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
3.0081 -21.8120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7146 -21.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4236 -21.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2644 -21.4830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9289 -22.6261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1301 -22.7985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7205 -22.0921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9059 -22.0947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4998 -22.8028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9144 -23.5099 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7277 -23.5039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0916 -20.6805 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4241 -22.6224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1322 -23.0288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8396 -22.6181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8345 -21.7966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1259 -21.3939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5491 -23.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5526 -23.8408 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2550 -22.6119 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9645 -23.0175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5376 -21.3863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2482 -21.7920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9528 -21.3795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9479 -20.5614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2326 -20.1576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5310 -20.5725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5365 -23.1727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 7 1 0
6 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 12 2 0
3 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 3 1 0
15 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
16 22 1 0
5 28 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 373.37 | Molecular Weight (Monoisotopic): 373.1063 | AlogP: 2.66 | #Rotatable Bonds: 4 |
Polar Surface Area: 99.60 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.94 | CX Basic pKa: 1.88 | CX LogP: 1.92 | CX LogD: 1.91 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.42 | Np Likeness Score: -0.93 |
References
1. Mak JYW,Wu KC,Gupta PK,Barbero S,McLaughlin MG,Lucke AJ,Tng J,Lim J,Loh Z,Sweet MJ,Reid RC,Liu L,Fairlie DP. (2021) HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates., 64 (4.0): [PMID:33570940] [10.1021/acs.jmedchem.0c01967] |